For laboratory research use only.
Gonadorelin and triptorelin both act in the gonadotropin-releasing hormone (GnRH) pathway, but they are not the same peptide. Axis literacy—kisspeptin upstream, GnRH at the pituitary, gonadotropins downstream—prevents expensive category errors.
Gonadorelin (GnRH)
Gonadorelin refers to GnRH itself, the hypothalamic decapeptide that stimulates pituitary LH and FSH secretion. Reviews of isolated GnRH deficiency illustrate how central the peptide is to reproductive endocrine control (isolated GnRH deficiency). Research materials labeled gonadorelin should match that native sequence expectation unless the label says otherwise.
Triptorelin as a GnRH agonist analog
Triptorelin is a synthetic GnRH agonist with amino-acid substitutions that change stability and pharmacology relative to native GnRH. Continuous agonist exposure paradigms historically produce different physiological patterns than pulsatile native GnRH—an experimental design theme described throughout reproductive endocrinology, not a personal-use instruction. Gonadotropin chapters provide receptor-level context for downstream LH/FSH actions (gonadotropins overview).
Receptor connections downstream
LH and hCG share the LHCGR; FSH has its own receptor. Recent receptor-regulation reviews detail allosteric and hormonal control of LHCGR (LH/hCG receptor regulation). That downstream biology is why GnRH agonists, hCG, and hMG are not interchangeable tools even when a project is loosely “reproductive.”
Distinctions checklist
- Gonadorelin ≠ triptorelin.
- GnRH ligands ≠ kisspeptin-10 (KISS1R upstream).
- GnRH agonists ≠ hCG or menotropin preparations.
Sources
- Isolated Gonadotropin-Releasing Hormone (GnRH) Deficiency. (1993, PMID 20301509)
- Gonadotropins. (2012, PMID 31644163)
- Hormonal and Allosteric Regulation of the Luteinizing Hormone/Chorionic Gonadotropin Receptor. (Front Biosci (Landmark Ed), 2024, PMID 39344322)